Exactly. Trading on December 17th indicated nothing as well. The market doesn't typically trade on anything it doesn't know. Sometimes traders make bets... but that's a different story.

Speaking of bets. Anyone think it's odd that enrollment in the mild/mod trial seemed to stall at 45 patients (a round 2:1 number) for roughly two weeks (endpoint time frame), and now we have an unexpected and vague conference call regarding clinical updates and regulatory developments? NP has hinted plenty that the FDA may be able to look at the data early. Not saying I'm banking on anything, but I do think that those are interesting coincidences.